PKI (14-24) amide
PKI (14-24) amide is a potent PKA inhibitor. PKI (14-24) amide strongly inhibited cyclic AMP-dependent protein kinase activity in the cell homogenate[1][2].
Product Specifications
CAS Number
100853-61-0
UNSPSC
12352209
Target
PKA
Type
Peptides
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pki-14-24-amide.html
Solubility
H2O
Smiles
N=C(N)NCCC[C@H](NC(CN)=O)C(N[C@@H]([C@H](O)C)C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(N)=O)C(N[C@@H](C)C(N[C@@H]([C@@H](C)CC)C(N[C@H](C(N[C@H](C(N)=O)CC(O)=O)=O)CC1=CN=CN1)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C49H86N24O15
Molecular Weight
1251.36
References & Citations
[1]Nörenberg W, et al. Adenosine A2A receptors inhibit the conductance of NMDA receptor channels in rat neostriatal neurons. Amino Acids. 1998;14 (1-3) :33-9. |[2]Takuma T. Evidence against direct involvement of cyclic AMP-dependent protein phosphorylation in the exocytosis of amylase. Biochem J. 1988 Dec 15;256 (3) :867-71.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
